hot topics on low-risk myelodysplastic syndromes (mds) from the 63rd ash annual meeting*
Published 2 years ago • 55 plays • Length 12:22Download video MP4
Download video MP3
Similar videos
-
9:54
lightning reports™ from ash 2022 on low and high-risk mds
-
9:14
lightning reports™ from ash 2022 on low and high-risk mds
-
6:37
low-risk mds updates from ash19
-
9:44
ash annual meeting 2020 - highlights in mds
-
1:40
mds 2023 highlights: classification and risk stratification systems & progression from ch to mds
-
2:00
key mds updates from the 2021 ash meeting
-
7:51
lower risk mds
-
1:11
highlights in mds from ash 2018
-
1:27
exciting updates in higher-risk mds at ash 2022
-
4:28
current and emerging treatment options for mds
-
1:40
highlights in lr-mds at the ash 2023 meeting
-
54:20
the myelodysplastic syndrome - past is prologue: insight to personalized therapy
-
1:36:38
highlights of ash 2016: mds 2/7/17
-
18:42
case discussion: high-risk myelodysplastic syndromes
-
1:13
dr gerds on unmet needs in low-risk myelofibrosis
-
3:52
ash impact series: david steensma, md - examining current research initiatives in mds
-
1:20
advances in diagnosis and management of myelodysplastic syndromes - virtual ash 2020 symposium
-
4:55
checkpoint inhibitor combination approaches for aml/mds: an update
-
2:16
updates in the myelodysplastic syndromes: 2023 best of hematology